Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00588640 · ClinicalTrials.gov registry record · Phase 1
Study of D-Methadone in Patients With Chronic Pain
A Phase 1 study, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
NCT00588640: Completed Phase 1 study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00588640 is a Phase 1 study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00588640, a Phase 1 study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the safest dose of d-methadone that can be given, without causing severe side effects in most patients with chronic pain. Patients are being asked to participate in the Phase I portion of this study.
Interventions
- DRUG placebo
- DRUG d-Methadone
- DRUG D-methadone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2004-10 |
| Est. Completion | 2008-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00588640
The ClinicalTrials.gov registry entry for NCT00588640 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which placebo is the first listed.
NCT00588640 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00588640 about?
NCT00588640 is a clinical study titled "Study of D-Methadone in Patients With Chronic Pain". The purpose of this study is to determine the safest dose of d-methadone that can be given, without causing severe side effects in most patients with chronic pain. Patients are being asked to participate in the Phase I portion of this study.
What is the current status of trial NCT00588640?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2004-10. Estimated completion is 2008-07.
What interventions are being tested in trial NCT00588640?
The interventions under investigation include: placebo (DRUG), d-Methadone (DRUG), D-methadone (DRUG).
Who is sponsoring clinical trial NCT00588640?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.